<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02491554</url>
  </required_header>
  <id_info>
    <org_study_id>P000847</org_study_id>
    <secondary_id>DRKS00008913</secondary_id>
    <nct_id>NCT02491554</nct_id>
  </id_info>
  <brief_title>Deep braIn Stimulation for Tremor TractographIC Versus Traditional</brief_title>
  <acronym>DISTINCT</acronym>
  <official_title>Deep braIn Stimulation for Tremor TractographIC Versus Traditional</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Freiburg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic Neuromodulation Europe</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Freiburg</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a monocentric, randomized, controlled, 2 arms, interventional, observer-blinded
      feasibility trial.

      Patients suffering from essential tremor (ET) will be treated with Deep Brain Stimulation
      (DBS). For the implantation of the DBS electrodes and the DBS system (Activa INS, Medtronic)
      patients will randomized either to conventional stereotactic surgery of thalamic/subthalamic
      region with short anesthesia or to MR-tractography guided stereotactic surgery with target
      point of the dentato-rubro-thalamic bundle (DRT) in general anesthesia.

      Patients will visit the study center at screening, baseline/neurosurgery, six and twelve
      months after neurosurgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this monocentric, randomized, controlled, 2 arms, interventional, observer-blinded
      feasibility trial patients suffering from therapy resistant essential tremor (ET) will be
      treated with Deep Brain Stimulation (DBS).

      After screening (e.g. obtaining informed consent, assessment of inclusion/exclusion criteria
      etc.) patients will be randomized to one of the following groups:

      Group 1 (conventional):

      Conventional AC-PC based DBS implantation in the thalamic/subthalamic region (Vim-cZI)
      starting as awake surgery with a brief general anesthesia for stimulator implantation at the
      end of surgery.

      Group 2 (tractographic):

      Magnetic resonance (MR)-tractography guided DBS implantation in the dentato-rubro-thalamic
      bundle (DRT) in general anesthesia

      At the baseline/neurosurgery visit Quality of Life (QoL) and other parameters will assessed.
      Medtronic's Activa INS DBS will be implanted according to randomization. DBS will be started
      approximately one month after surgery and will be applied as per routine.

      Patients will have their routine visits. For this trial data of the (routine) visits six and
      twelve months after neurosurgery will be collected.

      Patients receive DBS after the end of the trial according to local standards.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 2015</start_date>
  <completion_date type="Anticipated">June 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Tremor reduction defined by the difference in FTMTRS at 6 months after intervention to baseline</measure>
    <time_frame>Baseline, 6 months after neurosurgery</time_frame>
    <description>Tremor reduction defined by the difference in Fahn-Tolosa-Marin Tremor Rating Scale (FTMTRS) at 6 months after intervention to baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effective tremor reduction at 12 months after intervention</measure>
    <time_frame>Baseline, 12 months after neurosurgery</time_frame>
    <description>Effective tremor reduction (an FTMTRS score reduction by 50% compared to baseline is regarded as &quot;response&quot;) at 12 months after intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tremor reduction measured by tremor analysis at baseline and 6 and 12 months after intervention</measure>
    <time_frame>Baseline, 6 and 12 months after neurosurgery</time_frame>
    <description>Tremor reduction will be measured by tremor analysis (an accelerometric examination); Unit: Hertz (Hz)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tremor reduction measured by calculation of total power at baseline and 6 and 12 months after intervention</measure>
    <time_frame>Baseline, 6 and 12 months after neurosurgery</time_frame>
    <description>Tremor reduction will be assessed during Electromyography (EMG) by the calculation of total power; Unit: mg², with g=9,81 m/s²</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life: QUEST, SF-36</measure>
    <time_frame>Baseline, 6 and 12 months after neurosurgery</time_frame>
    <description>Qualitiy of Life assessed by Quality of Life Essential Tremor Questionnaire (QUEST) and Short Form (36) Health Survey</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Size of VAT</measure>
    <time_frame>Day 0 (Day of neurosurgery)</time_frame>
    <description>Size of Volume of activated tissue (VAT)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effective contact position with respect to DRT and AC-PC coordinates</measure>
    <time_frame>Day 0 (Day of neurosurgery)</time_frame>
    <description>Effective contact position of stimulation electrodes (with respect to the Dentato-rubro-thalamic bundle (DRT) and anterior commissure (AC) - posterior commissure (PC) line (ACPC) coordinaties)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of neurosurgery</measure>
    <time_frame>Day 0 (Day of neurosurgery)</time_frame>
    <description>Duration of neurosurgery (time points of mounting frame, start surgery, stop surgery (= dismounting frame)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in BDI</measure>
    <time_frame>Baseline, 6 and 12 months after neurosurgery</time_frame>
    <description>Psychiatric assessment: changes in Beck's Depression Inventory (BDI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of (Serious) Adverse Events related to intervention</measure>
    <time_frame>Up to 12 months after neurosurgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Essential Tremor</condition>
  <arm_group>
    <arm_group_label>Conventional AC-PC based implantation of ACTIVA INS DBS system</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional AC-PC based DBS implantation in the thalamic/subthalamic region (Vim-cZI) starting as awake surgery with a brief general anesthesia for stimulator implantation at the end of surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MR-tractography guided implantation of ACTIVA INS DBS system</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>MR-tractography guided DBS implantation in the dentato-rubro-thalamic bundle (DRT) in general anesthesia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Conventional AC-PC based implantation of ACTIVA INS DBS system</intervention_name>
    <description>Conventional AC-PC based implantation of ACTIVA INS DBS system (manufactured by Medtronic) in the thalamic/subthalamic region (Vim-cZI).</description>
    <arm_group_label>Conventional AC-PC based implantation of ACTIVA INS DBS system</arm_group_label>
    <other_name>Medtronic ACTIVA INS Deep Brain Stimulation system</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MR-tractography guided implantation of ACTIVA INS DBS system</intervention_name>
    <description>MR-tractography guided implantation of ACTIVA INS DBS system (manufactured by Medtronic) in the DRT.</description>
    <arm_group_label>MR-tractography guided implantation of ACTIVA INS DBS system</arm_group_label>
    <other_name>Medtronic ACTIVA INS Deep Brain Stimulation system</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male or female patients aged ≥ 25 and ≤ 80 years

          2. Patients with Essential Tremor according to the criteria of the consensus statement of
             the movement disorders society (Deuschl et al. 1998) are included with a medical
             treatment resistant and disabling postural and/or intentional tremor.

          3. FTMTRS to be completed within 42 days prior surgery

          4. Stable tremor medication for at least 3 months prior inclusion

          5. Written informed consent

        Exclusion Criteria:

          1. Major Depression with suicidal thoughts or suicidal thoughts in history

          2. Dementia (Mattis Dementia Rating Score ≤ 130)

          3. Acute psychosis

          4. Patient incapability

          5. Nursing care at home

          6. Surgical contraindications

          7. Medications that are likely to cause interactions in the opinion of the investigator

          8. Known or persistent abuse of medication, drugs or alcohol

          9. Persons who are in a relationship of dependence/employment with the sponsor or the
             investigator

         10. Fertile women not using adequate contraceptive methods: female condoms, diaphragm or
             coil, each used in combination with spermicides; intra-uterine device; hormonal
             contraception in combination with a mechanical method of contraception;

         11. Current or planned pregnancy, nursing period
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Volker A Coenen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Freiburg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Volker A Coenen, MD</last_name>
    <phone>+49 761 270</phone>
    <phone_ext>50630</phone_ext>
    <email>stereotaxie@uniklinik-freiburg.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Peter Reinacher, MD</last_name>
    <phone>+49 761 270</phone>
    <phone_ext>50680</phone_ext>
    <email>peter.reinacher@uniklinik-freiburg.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Freiburg - Medical Center - Dept. of Stereotactic and Functional Neurosurgery</name>
      <address>
        <city>Freiburg</city>
        <zip>79110</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Volker Coenen, MD</last_name>
      <phone>+49 761 270</phone>
      <phone_ext>50630</phone_ext>
      <email>volker.coenen@uniklinik-freiburg.de</email>
    </contact>
    <contact_backup>
      <last_name>Fabian Schubach</last_name>
      <phone>+49 761 270</phone>
      <phone_ext>77763</phone_ext>
      <email>fabian.schubach@uniklinik-freiburg.de</email>
    </contact_backup>
    <investigator>
      <last_name>Volker Coenen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Peter Reinacher, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bastian Sajonz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas Prokop, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Trippel, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Zappia M, Albanese A, Bruno E, Colosimo C, Filippini G, Martinelli P, Nicoletti A, Quattrocchi G, Abbruzzese G, Berardelli A, Allegra R, Aniello MS, Elia AE, Martino D, Murgia D, Picillo M, Squintani G. Treatment of essential tremor: a systematic review of evidence and recommendations from the Italian Movement Disorders Association. J Neurol. 2013 Mar;260(3):714-40. doi: 10.1007/s00415-012-6628-x. Epub 2012 Aug 11. Review. Erratum in: J Neurol. 2013 Mar;260(3):741. Abbruzzese, Giovanni [added]; Berardelli, Alfredo [added]; Allegra, Roberta [added]; Aniello, Maria Stella [added]; Elia, Antonio E [added]; Martino, Davide [added]; Murgia, Daniela [added]; Picillo, Marina [added]; Squintani, Giovanna [added].</citation>
    <PMID>22886006</PMID>
  </reference>
  <reference>
    <citation>Koller W, Biary N, Cone S. Disability in essential tremor: effect of treatment. Neurology. 1986 Jul;36(7):1001-4.</citation>
    <PMID>2940473</PMID>
  </reference>
  <reference>
    <citation>Chopra A, Klassen BT, Stead M. Current clinical application of deep-brain stimulation for essential tremor. Neuropsychiatr Dis Treat. 2013;9:1859-65. doi: 10.2147/NDT.S32342. Epub 2013 Dec 2. Review.</citation>
    <PMID>24324335</PMID>
  </reference>
  <reference>
    <citation>Benabid AL, Pollak P, Gao D, Hoffmann D, Limousin P, Gay E, Payen I, Benazzouz A. Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders. J Neurosurg. 1996 Feb;84(2):203-14.</citation>
    <PMID>8592222</PMID>
  </reference>
  <reference>
    <citation>Deistung A, Schäfer A, Schweser F, Biedermann U, Turner R, Reichenbach JR. Toward in vivo histology: a comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2*-imaging at ultra-high magnetic field strength. Neuroimage. 2013 Jan 15;65:299-314. doi: 10.1016/j.neuroimage.2012.09.055. Epub 2012 Oct 2.</citation>
    <PMID>23036448</PMID>
  </reference>
  <reference>
    <citation>Lemaire JJ, Sakka L, Ouchchane L, Caire F, Gabrillargues J, Bonny JM. Anatomy of the human thalamus based on spontaneous contrast and microscopic voxels in high-field magnetic resonance imaging. Neurosurgery. 2010 Mar;66(3 Suppl Operative):161-72. doi: 10.1227/01.NEU.0000365617.41061.A3.</citation>
    <PMID>20173566</PMID>
  </reference>
  <reference>
    <citation>Coenen VA, Allert N, Mädler B. A role of diffusion tensor imaging fiber tracking in deep brain stimulation surgery: DBS of the dentato-rubro-thalamic tract (drt) for the treatment of therapy-refractory tremor. Acta Neurochir (Wien). 2011 Aug;153(8):1579-85; discussion 1585. doi: 10.1007/s00701-011-1036-z. Epub 2011 May 8.</citation>
    <PMID>21553318</PMID>
  </reference>
  <reference>
    <citation>Coenen VA, Allert N, Paus S, Kronenbürger M, Urbach H, Mädler B. Modulation of the cerebello-thalamo-cortical network in thalamic deep brain stimulation for tremor: a diffusion tensor imaging study. Neurosurgery. 2014 Dec;75(6):657-69; discussion 669-70. doi: 10.1227/NEU.0000000000000540.</citation>
    <PMID>25161000</PMID>
  </reference>
  <reference>
    <citation>Coenen VA, Mädler B, Schiffbauer H, Urbach H, Allert N. Individual fiber anatomy of the subthalamic region revealed with diffusion tensor imaging: a concept to identify the deep brain stimulation target for tremor suppression. Neurosurgery. 2011 Apr;68(4):1069-75; discussion 1075-6. doi: 10.1227/NEU.0b013e31820a1a20. Erratum in: Neurosurgery. 2011 Jun;68(6):E1780-1.</citation>
    <PMID>21242831</PMID>
  </reference>
  <reference>
    <citation>Torres CV, Manzanares R, Sola RG. Integrating diffusion tensor imaging-based tractography into deep brain stimulation surgery: a review of the literature. Stereotact Funct Neurosurg. 2014;92(5):282-90. doi: 10.1159/000362937. Epub 2014 Sep 18. Review.</citation>
    <PMID>25248076</PMID>
  </reference>
  <reference>
    <citation>Klein JC, Barbe MT, Seifried C, Baudrexel S, Runge M, Maarouf M, Gasser T, Hattingen E, Liebig T, Deichmann R, Timmermann L, Weise L, Hilker R. The tremor network targeted by successful VIM deep brain stimulation in humans. Neurology. 2012 Mar 13;78(11):787-95. doi: 10.1212/WNL.0b013e318249f702. Epub 2012 Feb 29.</citation>
    <PMID>22377809</PMID>
  </reference>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 30, 2015</study_first_submitted>
  <study_first_submitted_qc>July 2, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 8, 2015</study_first_posted>
  <last_update_submitted>November 9, 2017</last_update_submitted>
  <last_update_submitted_qc>November 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Freiburg</investigator_affiliation>
    <investigator_full_name>Prof. Dr. Volker Arnd Coenen</investigator_full_name>
    <investigator_title>Prof. Dr. med.</investigator_title>
  </responsible_party>
  <keyword>Deep Brain Stimulation</keyword>
  <keyword>Essential tremor</keyword>
  <keyword>DISTINCT</keyword>
  <keyword>MR-tractography guided DBS implantation</keyword>
  <keyword>Conventional AC-PC based DBS implantation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tremor</mesh_term>
    <mesh_term>Essential Tremor</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

